The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | Genetic subtypes of cHL identified by non-invasive genomic profiling
Stefan Alig, MD, Stanford University School of Medicine, Stanford, CA, shares the findings of a study which used non-invasive genomic profiling to identify genetic subtypes of classic Hodgkin lymphoma (cHL). Dr Alig begins by discussing the approach used to profile a large cohort of patients using CAPP-seq, before describing two biologically distinct mutational subtypes that were identified. These two clusters had distinct transcriptional signatures and correlated with clinical variables. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Honoraria: Takeda Pharmaceuticals
